Dissemination To Healthcare System Leaders Rethinking Clinical Trials

Dissemination To Healthcare System Leaders Rethinking Clinical Trials Health system leaders prefer information on effectiveness over efficacy, evidence that is distilled, and results that are actionable (white et al. 2017). explain how adopting the intervention could work in their health system context. In this section, we suggest practical strategies and recommend tools for sharing study findings with healthcare system partners—beyond the usual journal publications and professional conferences. study teams should tailor the messages and media to the needs and priorities of the health system.

Dissemination To Healthcare System Leaders Rethinking Clinical Trials This chapter explores dissemination strategies for different stakeholders, beginning with considerations for transparent reporting to the scientific community and then moving to approaches for disseminating to patients and health systems leaders. Dissemination to healthcare system leaders: dissemination points. in: rethinking clinical trials: a living textbook of pragmatic clinical trials. bethesda, md: nih pragmatic trials collaboratory. available at: rethinkingclinicaltrials.org chapters dissemination dissemination different stakeholders dissemination to health system leaders. We represent healthcare systems leaders and researchers who have partnered with the nih collaboratory trials. through our experience, we have learned that the successful conduct of epcts requires shared vision and priorities, continuous communication and commitment, and, frequently, compromise. The nih pragmatic trials collaboratory published a new handout describing the variety of dissemination opportunities for pragmatic clinical trials to help investigators plan for broad dissemination.

Dissemination To Healthcare System Leaders Rethinking Clinical Trials We represent healthcare systems leaders and researchers who have partnered with the nih collaboratory trials. through our experience, we have learned that the successful conduct of epcts requires shared vision and priorities, continuous communication and commitment, and, frequently, compromise. The nih pragmatic trials collaboratory published a new handout describing the variety of dissemination opportunities for pragmatic clinical trials to help investigators plan for broad dissemination. To ensure timely, comprehensive, accurate, unbiased, unambiguous and transparent dissemination, all research stakeholders should integrate ethics and integrity principles in their institutional dissemination policies and personal belief systems. It provides advice from the nih pragmatic trials collaboratory and serves as an annotated table of contents, pointing readers to essential content in the living textbook of pragmatic clinical trials regarding partnering to conduct an epct. Dissemination and implementation strategies vary for different types of interventions and trials, and are ultimately tied to the evidence that comes from a trial. The hra’s publication and dissemination of research findings webpage sets out good practice expectations for researchers and sponsors, including timely reporting, appropriate choice of dissemination routes, and alignment with regulatory and ethical requirements.

Dissemination To Healthcare System Leaders Rethinking Clinical Trials To ensure timely, comprehensive, accurate, unbiased, unambiguous and transparent dissemination, all research stakeholders should integrate ethics and integrity principles in their institutional dissemination policies and personal belief systems. It provides advice from the nih pragmatic trials collaboratory and serves as an annotated table of contents, pointing readers to essential content in the living textbook of pragmatic clinical trials regarding partnering to conduct an epct. Dissemination and implementation strategies vary for different types of interventions and trials, and are ultimately tied to the evidence that comes from a trial. The hra’s publication and dissemination of research findings webpage sets out good practice expectations for researchers and sponsors, including timely reporting, appropriate choice of dissemination routes, and alignment with regulatory and ethical requirements.

Nih Collaboratory Rethinking Clinical Trials The Living Textbook Dissemination and implementation strategies vary for different types of interventions and trials, and are ultimately tied to the evidence that comes from a trial. The hra’s publication and dissemination of research findings webpage sets out good practice expectations for researchers and sponsors, including timely reporting, appropriate choice of dissemination routes, and alignment with regulatory and ethical requirements.

Nih Collaboratory Rethinking Clinical Trials The Living Textbook